Redwood Wealth Management Group, LLC Invitae Corp Transaction History

Redwood Wealth Management Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$0.0 - $0.01 $0 - $282	28,205 New	28,205 $254,000
Q4 2023 Jan 25, 2024	SELL	$0.42 - $0.72 $5,691 - $9,756	-13,550 Reduced 29.58%	32,255 $20.2 Million
Q3 2023 Oct 18, 2023	SELL	$0.6 - $1.53 $60 - $153	-100 Reduced 0.22%	45,805 $27.7 Million
Q2 2023 Jul 20, 2023	BUY	$1.05 - $1.63 $945 - $1,467	900 Added 2.0%	45,905 $51.9 Million
Q1 2023 Apr 19, 2023	BUY	$1.2 - $2.73 $4,986 - $11,343	4,155 Added 10.17%	45,005 $60.8 Million
Q4 2022 Feb 01, 2023	BUY	$1.71 - $3.61 $69,853 - $147,468	40,850 New	40,850 $76 Million

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Redwood Wealth Management Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redwood Wealth Management Group, LLC with notifications on news.